Screening compound: OPEPLHMCIPBCMK-SFHVURJKSA-N

Screening compound: OPEPLHMCIPBCMK-SFHVURJKSA-N
Screening compound: OPEPLHMCIPBCMK-SFHVURJKSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
OPEPLHMCIPBCMK-SFHVURJKSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0645

Molecular Formula

C23H24FN5O3 (C23 H24 FN5 O3)

Compound Name

N-(3-fluoro-4-methylphenyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane-2-carboxamide

IUPAC name

N-(3-fluoro-4-methylphenyl)-4-[5-(pyridin-4-yl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane-2-carboxamide

SMILES

Cc(ccc(NC(N(C1)CC2(CCOCC2)C1c1nnc(-c2ccncc2)o1)=O)c1)c1F

InChI

InChI=1S/C23H24FN5O3/c1-15-2-3-17(12-19(15)24)26-22(30)29-13-18(23(14-29)6-10-31-11-7-23)21-28-27-20(32-21)16-4-8-25-9-5-16/h2-5,8-9,12,18H,6-7,10-11,13-14H2,1H3,(H,26,30)/t18-/m0/s1

InChI Key

OPEPLHMCIPBCMK-SFHVURJKSA-N

MDL Number (MFCD)

MFCD29004264

OPEPLHMCIPBCMK-SFHVURJKSA-N in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with OPEPLHMCIPBCMK-SFHVURJKSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound OPEPLHMCIPBCMK-SFHVURJKSA-N?
Check Price and Availability of OPEPLHMCIPBCMK-SFHVURJKSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of OPEPLHMCIPBCMK-SFHVURJKSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for OPEPLHMCIPBCMK-SFHVURJKSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for OPEPLHMCIPBCMK-SFHVURJKSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of OPEPLHMCIPBCMK-SFHVURJKSA-N available by request